Integrating hands-on oncology-specific clinical expertise with real-time biomarker data analysis helps accelerate complex trials. Patricia Devitt Risse, President, Clinical Solutions, explains.
Over the 20+ years we’ve been running oncology clinical trials, we’ve developed a network of 70+ global centers of excellence, the Precision Oncology Site Network (OSN), for oncology and immuno-oncology studies. The OSN includes many of the world’s leading cancer research organizations, and our ongoing relationship with these sites translates into rapid study start-up (as little as 90 days for some sites), highly efficient operations, and dependable organizational quality.
These are just a few of our OSN sites: